Clinical Trial

Bevacizumab Versus Triamcinolone Acetonide for the Treatment of Keloids.

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The study compares the efficacy and safety of intralesional bevacizumab versus corticosteroids for the treatment of keloids. Assessment will be done clinically by the use of Modified Vancouver Scar Scale. Erythema index will be measured by spectrophotometry. The levels of Vascular Endothelial Growth Factor, collagen type 1 and collagen type 3 in the lesions before and after each treatment modality.
Trial Details
NCT Number NCT07014280
Lead Sponsor Kasr El Aini Hospital
Conditions Keloids
Enrollment 28 participants
Start Date 2023-09-01
Primary Completion 2024-09-01 (estimated)
Study Completion 2025-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-10